Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Skin cancer patch radiation shows promise in early trial

NCT ID NCT04480645

First seen Mar 28, 2026 · Last updated May 22, 2026 · Updated 7 times

Summary

This early study tested a new radiation patch (CivaDerm) for treating common skin cancers like basal cell and squamous cell carcinoma. Ten adults with small tumors on their trunk or limbs received the patch treatment. The goal was to see if the device could safely deliver targeted radiation to the skin surface. Researchers monitored skin side effects and how well the radiation reached the tumor.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CivaDerm Oncology PLLC

    Morrisville, North Carolina, 27560, United States

Conditions

Explore the condition pages connected to this study.